Wrapping antimicrobial peptides in hyaluronic acid nanogels maintained their bacteria-killing power while dramatically reducing their toxicity to human cells, improving the safety margin up to 16.8-fold.
16.8× saferNanogel encapsulation improved the selectivity index of the Ab-Cath peptide 16.8-fold, reaching ≥3,000 against drug-resistant A. baumannii
What the researchers found
Encapsulation of antimicrobial peptides SAAP-148 and Ab-Cath in oleyl-modified hyaluronic acid (OL-HA) nanogels maintained their antimicrobial activity against drug-resistant Staphylococcus aureus and Acinetobacter baumannii while significantly reducing toxicity to human cells.
The selectivity index improved 2-fold for SAAP-148 and 16.8-fold for Ab-Cath. Ab-Cath-loaded nanogels achieved a selectivity index of ≥300 for S. aureus and ≥3,000 for A. baumannii — levels that indicate strong clinical potential. The nanogels were 181-206 nm in size with 53-63% encapsulation efficiency.
Why it matters
Antibiotic resistance is one of the biggest threats to global health, and antimicrobial peptides are a promising alternative — but their toxicity to healthy cells has been a major roadblock to clinical use. This nanogel delivery system addresses that core problem by dramatically improving the safety margin without sacrificing effectiveness, potentially bringing peptide-based antibiotics closer to real-world medical use.
How the study worked
The researchers created nanogels from oleyl-modified hyaluronic acid and loaded them with two antimicrobial peptides. They characterized the physical properties of the nanogels (size, surface charge, encapsulation efficiency) and tested their antimicrobial activity against drug-resistant S. aureus and A. baumannii in vitro. Toxicity was assessed against human red blood cells and primary skin fibroblasts to calculate selectivity indices comparing bacteria-killing to cell-damaging concentrations.
What this study cannot tell us
This study was conducted entirely in laboratory settings (in vitro), so it remains unknown whether the nanogels would perform the same way in living organisms. The encapsulation efficiency of 53-63% means a significant portion of the peptide is not captured in the nanogels. Long-term stability, biodistribution, and potential immune responses to the nanogels were not assessed. The study tested only two bacterial species, so the approach may not generalize to all resistant pathogens.
How to read the evidence
This is a preclinical in vitro study demonstrating a drug delivery concept. While the results are promising and well-quantified, the findings have not been validated in animal models or clinical settings.
When this study was published
Published in 2023, this is recent research in the active field of antimicrobial peptide drug delivery, reflecting current approaches to overcoming the toxicity barrier for peptide therapeutics.
The bigger picture
This study represents an important advance in the broader effort to develop peptide-based alternatives to conventional antibiotics. While antimicrobial peptides have been studied for decades, their clinical translation has been limited by toxicity concerns. Nanoparticle delivery systems like these nanogels offer a practical engineering solution that could finally unlock the therapeutic potential of AMPs against the growing crisis of antimicrobial resistance.
Questions still open
- Would these peptide-loaded nanogels maintain their improved selectivity and antimicrobial activity in animal wound infection models?
- Can the encapsulation efficiency be improved beyond 53-63% to reduce material waste and cost?
- How do the nanogels perform against biofilm-forming bacteria, which are particularly challenging in clinical infections?
Common questions
What are antimicrobial peptides and why aren't they already used as antibiotics?
What is a selectivity index and why does it matter?
Read the original research
Encapsulation in oleyl-modified hyaluronic acid nanogels substantially improves the clinical potential of the antimicrobial peptides SAAP-148 and Ab-Cath.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 193, 254-261
Citation
van Gent, Miriam E; Klodzinska, Sylvia N; Drijfhout, Jan Wouter; Nielsen, Hanne M; Nibbering, Peter H. (2023). Encapsulation in oleyl-modified hyaluronic acid nanogels substantially improves the clinical potential of the antimicrobial peptides SAAP-148 and Ab-Cath.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 193, 254-261. https://doi.org/10.1016/j.ejpb.2023.11.005